REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,167,215 | +14.2% | 8,291,988 | 0.0% | 2.70% | +10.5% |
| Q2 2023 | $87,729,233 | +7.5% | 8,291,988 | 0.0% | 2.44% | -18.0% |
| Q1 2023 | $81,593,162 | -33.1% | 8,291,988 | 0.0% | 2.98% | -42.1% |
| Q4 2022 | $121,975,143 | +21.3% | 8,291,988 | 0.0% | 5.15% | +23.9% |
| Q3 2022 | $100,582,000 | -13.3% | 8,291,988 | 0.0% | 4.16% | -25.8% |
| Q2 2022 | $116,005,000 | +39.0% | 8,291,988 | +41.5% | 5.60% | +67.9% |
| Q1 2022 | $83,429,000 | -18.6% | 5,858,776 | +20.6% | 3.34% | -10.3% |
| Q4 2021 | $102,471,000 | +4.9% | 4,858,761 | +30.5% | 3.72% | -2.4% |
| Q3 2021 | $97,676,000 | -15.8% | 3,722,398 | 0.0% | 3.81% | -12.4% |
| Q2 2021 | $116,064,000 | +1.6% | 3,722,398 | 0.0% | 4.35% | +1.6% |
| Q1 2021 | $114,240,000 | +12.1% | 3,722,398 | +25.2% | 4.28% | +6.8% |
| Q4 2020 | $101,946,000 | +8.1% | 2,972,191 | -3.0% | 4.01% | -21.9% |
| Q3 2020 | $94,302,000 | +56.3% | 3,064,734 | +57.6% | 5.14% | +38.1% |
| Q2 2020 | $60,320,000 | – | 1,944,546 | – | 3.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
| MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
| MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
| BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
| Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
| Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
| Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
| CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
| Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |